Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

The FDA grants orphan drug and rare pediatric disease designations to LBPH's lead pipeline drug for the treatment of Dravet Syndrome. Data from a late-stage study shows that co-administering GSK's ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

After hours: September 27 at 4:45 PM EDT ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

Short-read (Illumina) 16S-EZ - For genus/species identification of bacteria and archaea - Targeted sequencing of 16S rRNA gene (V3 & V4 regions) - Short-read (Illumina) Full Length 16S - For ...

ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBE. Option for exclusive licence to highly sensitive NGS assay for use with CTCs and dual analysis of CTCs wit ...

In the rapidly evolving field of genomics, a new class of non-coding RNAs has captured the attention of researchers worldwide - circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs are ...

As you read this, a white box the size of a refrigerator is hurtling through space at 17,500 miles per hour (28,000 kph), ...

Refurbished DNA Sequencing platform Market. Refurbished DNA Sequencing Platform market – Comprehensive Study with focus on key drivers, trends, methodolo ...